Maricann Group Inc. (CSE:MARI; FWB:75M; OTCQB:MRRCF)is excited to announce the official launch of MariPlant, the Company’s European nutraceutical line of business. MariPlant products will be available for sale in Germany through www.mariplant.de beginning on August 20, 2018, with strategic expansion planned throughout the European Union.  Maricann’s first product launch is a soft gel formulation loaded with 25mg of CBD that utilizes the multi-patented VESIsorb® delivery system to ensure optimum absorption and bioavailability.

“Maricann is pleased to bring a superior CBD product to the German marketplace. This development symbolizes a significant move to strengthen our global leadership position as we introduce the first of many patented formulations that utilize VESIsorb,” Stated Ben Ward, CEO.


Maricann’s product launch represents many first-to-market milestones in the German cannabis industry, including the first:

  • VESIsorb® formulation specifically adapted for cannabinoids;
  • Standardized CBD product with measured and proven stability data; and
  • Formulation with a strategic CBD:BCP (beta-caryophyllene) ratio of 4:1

In 2017, through a commercialization agreement with SourceOne Global Partners, Maricann acquired the supply rights to VESIsorb® for use with cannabis for human consumption in Canada, Germany, and other territories.

Multiple clinical studies have demonstrated the absorption and bioavailability benefits of VESIsorb®, a science-backed drug delivery technology with a robust portfolio of international patents. VESIsorb® has now been successfully adapted to optimize the performance of cannabis formulations in the human body. Since 2007, close to 200 million consumers in all six continents have safely and effectively used a natural product formulated with VESIsorb®.

According to Jesse Lopez, CEO and founder of SourceOne Global Partners, Maricann’s commitment to building an immediate infrastructure for German market leadership has pioneered a new standard for cannabis products in Europe. “Maricann has all of the critical elements to champion the VESIsorb® drug delivery system in the emerging global cannabis industry. With a focus on innovation and clinical research, they also have the financial strength to build awareness and educate consumers on these superior product applications,” Lopez said.

About Maricann Group Inc.

Maricann is a vertically integrated producer and distributor of cannabis for medical purposes. The company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland. Maricann is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) facility and will continue to pursue new opportunities in Europe.

Forward Looking Statements

This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

Click here to connect with Maricann Group Inc. (CSE:MARI; FWB:75M; OTCQB:MRRCF) for an Investor Presentation

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less